Kennedy expands CDC panel criteria after court ruling

Health Secretary Robert F. Kennedy Jr. is reshaping the rules governing a key federal vaccine advisory group, days after a judge ruled that several of his appointees lacked the necessary qualifications.

The move marks the latest step in Kennedy’s broader effort to overhaul U.S. vaccine policy — and has reignited debate over the role and independence of scientific advisory panels.

Court ruling forces policy reset

The changes come after a federal judge in Boston found that the Advisory Committee on Immunization Practices (ACIP) had been unlawfully restructured.

The ruling concluded that many of the panel’s members were “distinctly unqualified,” noting that only a minority had meaningful experience in vaccines or immunization practices.

ACIP, which advises the Centers for Disease Control and Prevention, plays a central role in shaping recommendations such as the childhood vaccination schedule.

Broader criteria for panel membership

In response, the Department of Health and Human Services issued a revised charter expanding the range of acceptable expertise for committee members.

While previous requirements emphasized direct experience in vaccine research, clinical use and immunization practices, the updated framework allows for a wider range of specialties, including fields such as biostatistics and toxicology.

Officials said the update is part of routine administrative processes, though critics argue it could significantly alter the scientific standards guiding vaccine recommendations.

Ongoing debate over vaccine policy direction

The controversy reflects deeper tensions over Kennedy’s approach to public health. A longtime critic of vaccines, he has sought to reshape federal health policy since taking office.

Legal and political challenges may continue. The administration has not yet appealed the court’s decision, though it retains the option to do so within a 60-day window.

For now, the revised charter underscores a broader shift: a redefinition of who qualifies to guide U.S. vaccine policy — and how that policy is ultimately shaped.